Personalis EV 2011-2026 | PSNL

EV Jährlich Personalis

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
229 M	143 M	128 M	441 M	1.04 B	203 M	148 M	126 M	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
1.04 B	126 M	308 M

EV anderer Aktien in der Diagnostik & Forschung

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
Centogene N.V. CNTG	-19.1 M	-	-6.23 %	$ 30.6 M	Germany
Bioventus BVS	1.01 B	$ 9.26	1.09 %	$ 617 M	USA
Biodesix BDSX	142 M	$ 14.6	-3.63 %	$ 1.89 B	USA
DarioHealth Corp. DRIO	11 M	$ 8.45	9.74 %	$ 33.7 M	Israel
DexCom DXCM	28.2 B	$ 66.09	-1.12 %	$ 25.8 B	USA
Enzo Biochem ENZ	-22.7 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	22 B	-	-	$ 19.8 B	USA
Akumin AKU	1.64 B	-	-17.87 %	$ 25.9 M	Canada
Check-Cap Ltd. CHEK	2.55 M	-	-	$ 9.42 M	Israel
Heska Corporation HSKA	851 M	-	-	$ 1.31 B	USA
Oxford Immunotec Global PLC OXFD	26.2 M	-	-	$ 562 M	Britain
ICON Public Limited Company ICLR	26.4 B	$ 103.08	3.09 %	$ 8.5 B	Irlanda
IDEXX Laboratories IDXX	52.7 B	$ 573.29	-0.42 %	$ 46.1 B	USA
Illumina ILMN	15.3 B	$ 124.4	-1.43 %	$ 19.8 B	USA
DermTech DMTK	70.4 M	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	42.8 M	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	29.3 M	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	92.6 M	-	-61.36 %	$ 2.46 M	USA
Medpace Holdings MEDP	14 B	$ 466.6	-0.04 %	$ 13.5 B	USA
Global Cord Blood Corporation CO	-2.77 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	6.64 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	9.21 B	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	251 M	-	0.12 %	$ 80.1 M	China
Myriad Genetics MYGN	598 M	$ 4.62	-1.28 %	$ 428 M	USA
National Research Corporation NRC	432 M	$ 17.52	1.98 %	$ 392 M	USA
HTG Molecular Diagnostics HTGM	3.16 M	-	-20.0 %	$ 1.06 M	USA
Natera NTRA	5.53 B	$ 196.15	-0.62 %	$ 19.3 B	USA
PRA Health Sciences, Inc. PRAH	5.02 B	-	-	$ 10.7 B	USA
Charles River Laboratories International CRL	11.4 B	$ 165.13	-0.46 %	$ 8.18 B	USA
Organovo Holdings ONVO	-4.05 M	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	10.3 M	-	-16.95 %	$ 1.54 M	USA
OPKO Health OPK	1.62 B	$ 1.17	-1.68 %	$ 812 M	USA
Pacific Biosciences of California PACB	1.21 B	$ 1.35	-2.88 %	$ 405 M	USA
Biocept BIOC	15 M	-	-13.05 %	$ 7.29 M	USA
ENDRA Life Sciences NDRA	864 K	$ 4.59	22.4 %	$ 2.46 M	USA
PerkinElmer PKI	4 B	-	-0.91 %	$ 14.7 B	USA
Invitae Corporation NVTA	2.11 B	-	-	$ 21.2 M	USA
Interpace Biosciences IDXG	19.7 M	$ 1.73	2.37 %	$ 7.59 M	USA
RadNet RDNT	7.26 B	$ 59.41	-2.06 %	$ 4.47 B	USA
Motus GI Holdings MOTS	568 K	-	-34.28 %	$ 263 K	Israel
QIAGEN N.V. QGEN	11.3 B	-	-	$ 10.6 B	Niderland
Celcuity CELC	5.57 B	$ 114.81	4.16 %	$ 4.53 B	USA
Chembio Diagnostics CEMI	39.2 M	-	0.22 %	$ 16.8 M	USA
Senseonics Holdings SENS	376 M	$ 6.56	-2.96 %	$ 274 M	USA
Laboratory Corporation of America Holdings LH	33.1 B	$ 268.38	0.89 %	$ 22.3 B	USA
NeoGenomics NEO	1.85 B	$ 7.76	-0.13 %	$ 994 M	USA
Soleno Therapeutics SLNO	2.13 B	$ 31.83	-0.03 %	$ 1.62 B	USA
Psychemedics Corporation PMD	20.5 M	-	-1.84 %	$ 15.3 M	USA
Precipio PRPO	10.9 M	$ 27.2	-0.15 %	$ 35.3 M	USA